Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.21.1
Revenue from Contracts with Customers (Tables)
6 Months Ended
Mar. 31, 2021
Revenue from Contracts with Customers [Abstract]  
Revenue from Customers by Products



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Six Months Ended



March 31,

 

March 31,



2021

 

2020

 

2021

 

2020

FC2

 

 

 

 

 

 

 

 

 

 

 

U.S. prescription channel

$

10,312,742 

 

$

6,952,627 

 

$

19,414,481 

 

$

13,003,757 

Global public health sector

 

3,027,745 

 

 

2,569,644 

 

 

7,680,164 

 

 

6,943,438 

Total FC2

 

13,340,487 

 

 

9,522,271 

 

 

27,094,645 

 

 

19,947,195 

PREBOOST®

 

 -

 

 

420,833 

 

 

862,831 

 

 

573,925 

Net revenues

$

13,340,487 

 

$

9,943,104 

 

$

27,957,476 

 

$

20,521,120 



Revenue by Geographic Area





 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Six Months Ended



March 31,

 

March 31,



2021

 

2020

 

2021

 

2020



 

 

 

 

 

 

 

 

 

 

 

United States

$

10,612,998 

 

$

7,674,849 

 

$

20,968,836 

 

$

14,166,003 

Other

 

2,727,489 

 

 

2,268,255 

 

 

6,988,640 

 

 

6,355,117 

Net revenues

$

13,340,487 

 

$

9,943,104 

 

$

27,957,476 

 

$

20,521,120